Certolizumab-induced facial eruption in a pregnant woman with severe Behcet's disease.

O'Grady, Ciara; Quinn, Geraldine; Keogh, Anna; O'Keane, Conor; Murad, Aizuri

O'Grady, Ciara; Quinn, Geraldine; Keogh, Anna; O'Keane, Conor; Murad, Aizuri.

Afiliación

O'Grady C; Department of Dermatology, Mater Misercordiae University Hospital, Dublin, Ireland.
Quinn G; Department of Dermatology, Mater Misercordiae University Hospital, Dublin, Ireland.
Keogh A; Department of Histopathology, Mater Misercordiae University Hospital, Dublin, Ireland.
O'Keane C; Department of Histopathology, Mater Misercordiae University Hospital, Dublin, Ireland.
Murad A; Department of Dermatology, Mater Misercordiae University Hospital, Dublin, Ireland.

Dermatol Ther ; 33(6): e14162, 2020 11.

Article en En | MEDLINE | ID: mdl-32770724

Asunto(s)

Síndrome de Behçet; Exantema; Síndrome de Behçet/diagnóstico; Síndrome de Behçet/tratamiento farmacológico; Certolizumab Pegol/efectos adversos; Femenino; Humanos; Embarazo; Mujeres Embarazadas

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome de Behçet / Exantema Tipo de estudio: Diagnostic_studies Límite: Female / Humans / Pregnancy Idioma: En Revista: Dermatol Ther Asunto de la revista: DERMATOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Irlanda

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google